Last reviewed · How we verify

NCT05585619

Difficult Encounters in Pain Medicine

Completed Last updated 10 May 2024
What this trial tests

trial testing Pain treatment in Chronic Pain in 428 participants. Completed in 29 March 2024.

Timeline
10 October 2022
Primary endpoint
15 December 2023
29 March 2024

Quick facts

Lead sponsorJohns Hopkins University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment428
Start date10 October 2022
Primary completion15 December 2023
Estimated completion29 March 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are seeking to determine factors associated with difficult patient encounters in an academic pain clinic. The investigators are examining 36 different variables to determine the association with "difficult" patient encounters as independently rated by a trainee and attending physician.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Do difficult encounters affect pain treatment outcomes? A prospective cohort study.
    Liu WL, van Gelderen E, Mawalkar R, Wang EJ, et al · · 2025 · cited 2× · PMID 40100641 · DOI 10.1093/pm/pnaf027

Verify or expand the search:

Other trials of Pain treatment

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05585619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing